Stock warrant tracker
Every outstanding warrant series recorded in a Signal8 dilution snapshot, one row per series: the shares it can be exercised into, the exercise price (strike), the expiry date, whether the price can reset after a later financing, and the SEC filing each figure was read from. Exercise prices and share counts are restated for every stock split since the filing, so they compare directly with the current share price.
5,302 warrant series at 1,050 companies. 774 in the money, 58 expiring in the next 30 days, 37 waiting on a stockholder vote or other stated condition, 0 becoming exercisable in the next 30 days.
Outstanding warrants
| Series | Shares | Exercise price | Last price | Vs strike | Expiry | Exercisable | Terms | Overhang | Source | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Term Loan Warrants – February 2024 Term Loan May 2024 draw ($30.40) | $6.87 | $53.2M | 10-Q, Nov 5, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Term Loan Warrants – March 2025 Term Loan initial funding ($13.50) | $6.87 | $53.2M | 10-Q, Nov 5, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Term Loan Warrants – March 2025 Term Loan June 2025 draw ($14.80) | $6.87 | $53.2M | 10-Q, Nov 5, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| 2024 Credit Agreement lender warrants (June 24, 2024) – TCW and Asilia affiliates, $7.00 | $21.02 | $52.9M | 10-Q, Nov 5, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| December 2024 Amendment lender warrants (December 19, 2024) – TCW and Asilia affiliates, $23.86 | $21.02 | $52.9M | 10-Q, Nov 5, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Forum3 Inc. Coverage Warrant (August 1, 2025), $24.20 – vested portion | $21.02 | $52.9M | 10-Q, Nov 5, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| 2024 Underwriter Warrants (June 2024 public offering) | $1.18 | $52.5M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| 2025 Investor Warrants (July 2025 public offering, incl. over-allotment warrants) | $1.18 | $52.5M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| 2025 Underwriter Warrants (July 2025 public offering) | $1.18 | $52.5M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| November 2023 offering warrants (expiring November 24, 2028) — aggregate line | $1.18 | $52.5M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| Pre-Funded Warrants (Merger consideration, issued September 17, 2026) | $1.86 | $52.5M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Initial Closing Pre-Funded Warrants (Noteholder / Azora Note Exchange) | $3.67 | $52.4M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Initial Closing Pre-Funded Warrants (PIPE) | $3.67 | $52.4M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Milestone Incentive Warrants — MR Scout (Sept 30, 2026) | $3.67 | $52.4M | S-3/A, Oct 21, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Milestone Incentive Warrants — other Milestone Closings through Nov 6, 2026 | $3.67 | $52.4M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Milestone Pre-Funded Warrants — MR Scout (Sept 30, 2026) | $3.67 | $52.4M | S-3/A, Oct 21, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Milestone Pre-Funded Warrants — other Milestone Closings through Nov 6, 2026 | $3.67 | $52.4M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Placement Agent Series B-1 and C-1 Tail Warrants (May 2025) | $3.67 | $52.4M | 10-K, Mar 5, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Placement Agent Series D Tail Warrants (June 2025) | $3.67 | $52.4M | 10-K, Mar 5, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Placement Agent Warrants (March 2024 inducement) | $3.67 | $52.4M | S-3, Dec 12, 2025Dilution tabAs of Nov 17, 2026 | ||||||||
| Placement Agent Warrants (October 2023 private placement) | $3.67 | $52.4M | S-1, Nov 8, 2023Dilution tabAs of Nov 17, 2026 | ||||||||
| Series B-1 Warrants (May 2025 inducement) | $3.67 | $52.4M | 10-K, Mar 5, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Series D Warrants (June 2025 offering) | $3.67 | $52.4M | 10-K, Mar 5, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Series E Warrants (June 2025 offering) | $3.67 | $52.4M | 10-K, Mar 5, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Series F Warrants (Nov 2025 inducement) | $3.67 | $52.4M | DEF 14A, Aug 24, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Warrants issued February 10, 2022 (concurrent private placement) | $3.67 | $52.4M | S-1, Nov 8, 2023Dilution tabAs of Nov 17, 2026 | ||||||||
| Unit Purchase Option (Maxim) assumed from AIB Acquisition Corporation | $3.39 | $52.1M | 6-K EX-99.1, Nov 3, 2026Dilution tabAs of Nov 3, 2026 | ||||||||
| 2023 Compensation Warrants (underwriter) | $0.3825 | $52.1M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| 2023 Warrants (over-allotment, issued September 7, 2023) | $0.3825 | $52.1M | 10-K, Mar 30, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| 2023 Warrants (underwritten public offering, issued August 8, 2023) | $0.3825 | $52.1M | 10-K, Mar 30, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Assumed Signing Day Sports warrants (converted at Business Combination) | $0.6761 | $51.6M | S-1, Jun 2, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| June 2026 Representative Warrants – base offering (Lucid Capital Markets) | $0.6761 | $51.6M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| June 2026 Representative Warrants – over-allotment (Lucid Capital Markets) | $0.6761 | $51.6M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| February 2026 registered direct common warrants ($1.50) | $0.5800 | $51.5M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| June 2026 pre-funded warrants (Hivemind debt-for-equity exchange) | $0.5800 | $51.5M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| November 2025 private placement common warrants (amended exercise price $2.83) | $0.5800 | $51.5M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Warrants related to various prior period issuances (aggregate) | $0.5800 | $51.5M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Placement Agent Warrants (Wellington Shields, July 2024) | $5.06 | $51.4M | S-1/A, Jan 24, 2025Dilution tabAs of Nov 10, 2026 | ||||||||
| Purchaser Warrants (July 2024 PIPE) | $5.06 | $51.4M | S-1/A, Jan 24, 2025Dilution tabAs of Nov 10, 2026 | ||||||||
| Private Placement Warrants | $0.9415 | $51.1M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Public Warrants (FLYX WS) | $0.9415 | $51.1M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Series A Penny Warrants (March 4, 2024) | $0.9415 | $51.1M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Series B Penny Warrant – August 2024 (EG Sponsor) | $0.9415 | $51.1M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Series B Penny Warrant – August 2024 (EnTrust) | $0.9415 | $51.1M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Series B Penny Warrant – March 2025 (note cancellation) | $0.9415 | $51.1M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| April 2026 Note Warrants ($8.00, issued with April 24, 2026 Senior Secured Convertible Notes) | $0.8790 | $51.0M | 10-Q, Aug 28, 2026Dilution tabAs of Oct 29, 2026 | ||||||||
| August 8, 2025 Note Warrants - Investor B ($0.50, five-year) | $0.8790 | $51.0M | 10-Q, Aug 28, 2026Dilution tabAs of Oct 29, 2026 | ||||||||
| December 2, 2025 Note Warrants - Investor A ($0.50, five-year) | $0.8790 | $51.0M | 10-Q, Aug 28, 2026Dilution tabAs of Oct 29, 2026 | ||||||||
| May 8, 2025 Note Warrants - Investor C ($0.50, five-year) | $0.8790 | $51.0M | 10-Q, Aug 28, 2026Dilution tabAs of Oct 29, 2026 | ||||||||
| Pre-2024 warrants (outstanding at January 1, 2024; not itemised) | $0.8790 | $51.0M | 424B5, Sep 11, 2026Dilution tabAs of Oct 29, 2026 |
COCHEnvoy Medical, Inc.$6.87Last price
Term Loan Warrants – February 2024 Term Loan May 2024 draw ($30.40)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$53.2M
COCHEnvoy Medical, Inc.$6.87Last price
Term Loan Warrants – March 2025 Term Loan initial funding ($13.50)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$53.2M
COCHEnvoy Medical, Inc.$6.87Last price
Term Loan Warrants – March 2025 Term Loan June 2025 draw ($14.80)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$53.2M
RGSRegis Corporation$21.02Last price
2024 Credit Agreement lender warrants (June 24, 2024) – TCW and Asilia affiliates, $7.00
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$52.9M
RGSRegis Corporation$21.02Last price
December 2024 Amendment lender warrants (December 19, 2024) – TCW and Asilia affiliates, $23.86
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$52.9M
RGSRegis Corporation$21.02Last price
Forum3 Inc. Coverage Warrant (August 1, 2025), $24.20 – vested portion
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$52.9M
GANXGain Therapeutics, Inc.$1.18Last price
2024 Underwriter Warrants (June 2024 public offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$52.5M
GANXGain Therapeutics, Inc.$1.18Last price
2025 Investor Warrants (July 2025 public offering, incl. over-allotment warrants)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$52.5M
GANXGain Therapeutics, Inc.$1.18Last price
2025 Underwriter Warrants (July 2025 public offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$52.5M
GANXGain Therapeutics, Inc.$1.18Last price
November 2023 offering warrants (expiring November 24, 2028) — aggregate line
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$52.5M
HOSTHost Digital Inc.$1.86Last price
Pre-Funded Warrants (Merger consideration, issued September 17, 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$52.5M
AZRAzora Therapeutics, Inc.$3.67Last price
Initial Closing Pre-Funded Warrants (Noteholder / Azora Note Exchange)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$52.4M
AZRAzora Therapeutics, Inc.$3.67Last price
Initial Closing Pre-Funded Warrants (PIPE)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$52.4M
AZRAzora Therapeutics, Inc.$3.67Last price
Milestone Incentive Warrants — MR Scout (Sept 30, 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$52.4M
AZRAzora Therapeutics, Inc.$3.67Last price
Milestone Incentive Warrants — other Milestone Closings through Nov 6, 2026
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$52.4M
AZRAzora Therapeutics, Inc.$3.67Last price
Milestone Pre-Funded Warrants — MR Scout (Sept 30, 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$52.4M
AZRAzora Therapeutics, Inc.$3.67Last price
Milestone Pre-Funded Warrants — other Milestone Closings through Nov 6, 2026
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$52.4M
AZRAzora Therapeutics, Inc.$3.67Last price
Placement Agent Series B-1 and C-1 Tail Warrants (May 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$52.4M
AZRAzora Therapeutics, Inc.$3.67Last price
Placement Agent Series D Tail Warrants (June 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$52.4M
AZRAzora Therapeutics, Inc.$3.67Last price
Placement Agent Warrants (March 2024 inducement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$52.4M
AZRAzora Therapeutics, Inc.$3.67Last price
Placement Agent Warrants (October 2023 private placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$52.4M
AZRAzora Therapeutics, Inc.$3.67Last price
Series B-1 Warrants (May 2025 inducement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$52.4M
AZRAzora Therapeutics, Inc.$3.67Last price
Series D Warrants (June 2025 offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$52.4M
AZRAzora Therapeutics, Inc.$3.67Last price
Series E Warrants (June 2025 offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$52.4M
AZRAzora Therapeutics, Inc.$3.67Last price
Series F Warrants (Nov 2025 inducement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$52.4M
AZRAzora Therapeutics, Inc.$3.67Last price
Warrants issued February 10, 2022 (concurrent private placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$52.4M
PSIGPS International Group Ltd. Ordinary Shares$3.39Last price
Unit Purchase Option (Maxim) assumed from AIB Acquisition Corporation
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$52.1M
ONCYOncolytics Biotech Inc.$0.3825Last price
2023 Compensation Warrants (underwriter)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$52.1M
ONCYOncolytics Biotech Inc.$0.3825Last price
2023 Warrants (over-allotment, issued September 7, 2023)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$52.1M
ONCYOncolytics Biotech Inc.$0.3825Last price
2023 Warrants (underwritten public offering, issued August 8, 2023)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$52.1M
AIBAIB Data Centers Inc.$0.6761Last price
Assumed Signing Day Sports warrants (converted at Business Combination)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$51.6M
AIBAIB Data Centers Inc.$0.6761Last price
June 2026 Representative Warrants – base offering (Lucid Capital Markets)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$51.6M
AIBAIB Data Centers Inc.$0.6761Last price
June 2026 Representative Warrants – over-allotment (Lucid Capital Markets)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$51.6M
UPXIUpexi, Inc.$0.5800Last price
February 2026 registered direct common warrants ($1.50)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$51.5M
UPXIUpexi, Inc.$0.5800Last price
June 2026 pre-funded warrants (Hivemind debt-for-equity exchange)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$51.5M
UPXIUpexi, Inc.$0.5800Last price
November 2025 private placement common warrants (amended exercise price $2.83)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$51.5M
UPXIUpexi, Inc.$0.5800Last price
Warrants related to various prior period issuances (aggregate)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$51.5M
TPCSTechPrecision Corporation$5.06Last price
Placement Agent Warrants (Wellington Shields, July 2024)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$51.4M
TPCSTechPrecision Corporation$5.06Last price
Purchaser Warrants (July 2024 PIPE)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$51.4M
FLYXflyExclusive, Inc.$0.9415Last price
Private Placement Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$51.1M
FLYXflyExclusive, Inc.$0.9415Last price
Public Warrants (FLYX WS)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$51.1M
FLYXflyExclusive, Inc.$0.9415Last price
Series A Penny Warrants (March 4, 2024)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$51.1M
FLYXflyExclusive, Inc.$0.9415Last price
Series B Penny Warrant – August 2024 (EG Sponsor)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$51.1M
FLYXflyExclusive, Inc.$0.9415Last price
Series B Penny Warrant – August 2024 (EnTrust)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$51.1M
FLYXflyExclusive, Inc.$0.9415Last price
Series B Penny Warrant – March 2025 (note cancellation)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$51.1M
FBDTFirst Breach Inc.$0.8790Last price
April 2026 Note Warrants ($8.00, issued with April 24, 2026 Senior Secured Convertible Notes)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$51.0M
FBDTFirst Breach Inc.$0.8790Last price
August 8, 2025 Note Warrants - Investor B ($0.50, five-year)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$51.0M
FBDTFirst Breach Inc.$0.8790Last price
December 2, 2025 Note Warrants - Investor A ($0.50, five-year)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$51.0M
FBDTFirst Breach Inc.$0.8790Last price
May 8, 2025 Note Warrants - Investor C ($0.50, five-year)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$51.0M
FBDTFirst Breach Inc.$0.8790Last price
Pre-2024 warrants (outstanding at January 1, 2024; not itemised)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$51.0M
Source: SEC filings cited in each company’s dilution snapshot, compiled by Signal8, as of November 17, 2026.
Read from 2,062 dilution snapshots. 4,848 of 5,302 series state an exercise price and 3,366 an expiry date. 121 record when exercise begins; that count grows as companies are re-extracted. 631 series are left off because their figures could not be restated for a stock split. 20 companies and 0 series are held back pending review. Share counts, exercise prices, expiry dates and terms are included in Signal8 Pro. Not investment advice.
About this list
Most of the companies listed are small caps and penny stocks, where warrants are routinely issued with registered direct offerings, PIPEs and underwritten unit deals. When a warrant is exercised the company issues new shares, so the list is a record of shares that do not exist yet but can be issued.
Coverage is limited to the companies Signal8 has a dilution snapshot for. A company that is not listed may still have warrants outstanding, and a figure shown as Not stated was not found in the filings read, which is not a statement that it is zero.
The date a warrant first becomes exercisable is recorded only for companies extracted since Signal8 started reading it. Not recorded yet means the snapshot predates that field, not that the warrant is exercisable. Coverage grows as companies are re-extracted.
Frequently asked questions
- What is a stock warrant?
- A warrant gives its holder the right to buy new shares from the company at a fixed exercise price until an expiry date. When warrants are exercised the company issues new shares, which adds to the share count. Unlike an exchange-listed option, a warrant is issued by the company itself, usually alongside a financing.
- What does in the money mean for a warrant?
- A warrant is in the money when the current share price is above its exercise price, so exercising it costs less than buying the shares on the market. This page compares the last price with the exercise price after restating both for any stock split, and says No recent price when there is no price from the last 7 days.
- Which warrants are expiring soon?
- Each row shows the expiry date stated in the filing, and series that expire within 30 days are marked. A warrant that is not exercised by its expiry date lapses and no shares are issued for it. A row whose stated date has passed says so; the filing record does not show whether that series was exercised before it lapsed.
- What is a warrant exercise price reset or full ratchet?
- Some warrants lower their exercise price if the company later sells shares more cheaply. A full ratchet resets it to the new lower price; a weighted-average adjustment moves it part of the way; some warrants reset on a set date to a price tied to the market. A lower exercise price can also raise the number of shares the warrant covers. The Terms column shows the adjustment the filing describes.
- What is a pre-funded warrant?
- A pre-funded warrant is one where the buyer has already paid almost the whole price up front, leaving a nominal exercise price such as $0.0001 per share. It is in the money by construction, so this page marks it as such and does not rank it by distance from the strike.
- Why are exercise prices split-adjusted?
- Filings state exercise prices and share counts as of their filing date. After a reverse split a warrant covers fewer shares at a higher price. Signal8 restates both onto the current share basis; a series whose basis cannot be resolved is left off the page and counted under the table, rather than shown as filed.
- What is warrant overhang?
- Overhang is the number of shares the warrants can be exercised into, shown here as a percentage of shares outstanding, with both figures on the same split basis. Not measured means one of the two figures is missing.
- Where does the data come from and how often is it updated?
- Each row is read from the SEC filings cited in that company’s Signal8 dilution snapshot, and the source filing link on every row opens the document the figures were taken from. The list is rebuilt from the latest snapshots at least every 30 minutes, and each row shows the date of the snapshot it was read from.
Related
- PIPE tracker: private placements and registered directs
- Pending S-1 filings: offerings not yet effective
- Reverse split calendar
- Recently delisted stocks
- High dilution scanner
- Stock dilution checker
- Warrant overhang: how to count shares not issued yet
- Warrant price resets and ratchets explained
- Warrant inducements explained
- Warrants vs options
- How to read the Signal8 dilution tab
Not investment advice.